Dolo-Spedifen 200
Dolo-Spedifen 200 is a medicine authorised by Swissmedic under authorisation number 54878. The authorisation holder is Zambon Svizzera SA. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 16 June 1998 and the authorisation is valid without a time limit. ATC code M01AE01 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 54878 |
|---|---|
| Name | Dolo-Spedifen 200 |
| Full name | Dolo-Spedifen 200, granulare |
| Authorisation holder | Zambon Svizzera SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | M01AE01 |
| First authorisation | 16 June 1998 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dolo-Spedifen 200, granulare | D | 16 June 1998 |
| 2 | Dolo-Spedifen forte 400, granulare | D | 04 April 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Sachet(s) | M01AE01 | 07.10.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dolo-Spedifen 200 authorised in Switzerland?
Yes. Dolo-Spedifen 200 is authorised by Swissmedic under authorisation number 54878, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dolo-Spedifen 200 have?
Dolo-Spedifen 200 is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Dolo-Spedifen 200?
The authorisation holder is Zambon Svizzera SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.